|
|
|
| Home > Media & Events |
 |
|
 |
| |
| News: |
| 21th of December, 2011 |
| |
 
An updated version of the ASINEX's Glycomimetic Library is now available for screening. Two novel "sugar-like" scaffolds have been generated via diastereoselective biomimetic synthetic approach. |
| |
| 7th of June, 2011 |
| |
ASINEX announces the first release of the Antibac Array will be available to customers from September 2011. This library of 5000 compounds is specifically designed to address the challenge of antibacterial drug discovery, and is capable of delivering excellent chemical starting points for completely new classes of antibacterials.
Browse the Brochure... |
| |
| 1st of June, 2011 |
| |
ASINEX announces the launch of its Minimalist Library - the most advanced library of natural product-like small molecules - which will be available to customers from September 2011.
The molecules are close mimetics of natural products such as terpenoids, macrocycles, carbohydrates and alkaloids and represent a unique research tool for probing various biological targets and applications including: preotein-protein interactions, ion channels, proteases, antibacterial, antiviral.
Browse the Brochure... |
| |
| 10th of November, 2010 |
| |
ASINEX launched the PPI Library - a rationally pre-designed collection of small molecules predicted to have an excellent likelihood of disrupting pharmacologically relevant protein-protein interactions.
Browse the Brochure... |
| |
| |
| |
| Events: |
March 13-14, 2012
Discovery Chemistry Congress and Exhibition
Munich, Germany
|
Dmitry Genis, CEO
Roman Kombarov, Project Manager
|
April 17-19, 2012
Drug Discovery Chemistry
San Diego, CA
USA
|
Roman Kombarov, Project Manager
Andrea Altieri, Head of Business Development
|
May 8 - 9, 2012
16th Annual Merck Technology Symposium
Long Branch, NJ
USA
|
Mark Parisi, Director
|
|
| Publications: |
| |
Natural Products Inform Library Design
http://www.genengnews.com/gen-articles/natural-products-inform-library-design/3154/
|
| |
BioCores: identification of a drug/natural product-based privileged structural motif for small-molecule lead discovery
http://www.springerlink.com/content/5v7811k43817725w/
|
| |
|
|
 |
|
 |
|
|
|
|
| |
|
